All about medicine, treatment of disease.

Additional Phase II Data Demonstrate Improvement In Reported Symptoms In Patients Who Still Experience GERD Symptoms Despite PPI Therapy

Adding AZD3355, a novel GABAB receptor agonist, to a proton pump inhibitor (PPI) in patients with Gastroesophageal Reflux Disease (GERD), resulted in a 35% reduction in the mean total number of reflux episodes 0-24 hours after dose, compared with placebo.[i] These data were presented at the Digestive Diseases Week annual meeting (DDW®, 30 May - 4 June, Chicago).
generic viagra online

Major Head, Neck And Shoulder Pain Study Targets Region With Nearly Five Million Inhabitants

Researchers at the University of Turin have launched a major initiative to prevent and

News of the day

Fecal Incontinence And Quality Of Life

Fecal incontinence (FI) is a normal part of aging, or the perception that no treatment is available. Doctors may fail to comprehend patient hints about diarrhea and FI or may be reluctant to ask about fecal leakage, perhaps because of their own embarrassment or the perception that FI is a trivial concern.